A retrospective medical chart review of clinical outcomes in children and adolescents with attention-deficit/hyperactivity disorder treated with guanfacine extended-release in routine Canadian clinical practice.
Judy van StralenSimerpal K GillChristopher J ReaumeKenneth HandelmanPublished in: Child and adolescent psychiatry and mental health (2021)
In Canadian routine clinical practice, most children and adolescents with ADHD treated with GXR experienced improvements in ADHD symptoms and in functionality both at school and at home.